MapLight Therapeutics Statistics
Total Valuation
MPLT has a market cap or net worth of $931.99 million. The enterprise value is $632.69 million.
Important Dates
The last earnings date was Thursday, March 26, 2026, before market open.
| Earnings Date | Mar 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MPLT has 44.02 million shares outstanding. The number of shares has increased by 1,079.16% in one year.
| Current Share Class | 40.91M |
| Shares Outstanding | 44.02M |
| Shares Change (YoY) | +1,079.16% |
| Shares Change (QoQ) | +3,963.69% |
| Owned by Insiders (%) | 2.35% |
| Owned by Institutions (%) | 34.73% |
| Float | 12.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.03 |
| P/TBV Ratio | 2.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.01, with a Debt / Equity ratio of 0.01.
| Current Ratio | 20.01 |
| Quick Ratio | 18.80 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -56.19% and return on invested capital (ROIC) is -36.07%.
| Return on Equity (ROE) | -56.19% |
| Return on Assets (ROA) | -34.29% |
| Return on Invested Capital (ROIC) | -36.07% |
| Return on Capital Employed (ROCE) | -36.50% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.21M |
| Employee Count | 133 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 18.12 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 67.65 |
| Average Volume (20 Days) | 241,160 |
Short Selling Information
The latest short interest is 1.36 million, so 3.08% of the outstanding shares have been sold short.
| Short Interest | 1.36M |
| Short Previous Month | 1.36M |
| Short % of Shares Out | 3.08% |
| Short % of Float | 10.66% |
| Short Ratio (days to cover) | 9.32 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -169.08M |
| Pretax Income | -161.15M |
| Net Income | -161.15M |
| EBITDA | -168.51M |
| EBIT | -169.08M |
| Earnings Per Share (EPS) | -$18.56 |
Full Income Statement Balance Sheet
The company has $305.10 million in cash and $5.80 million in debt, with a net cash position of $299.30 million or $6.80 per share.
| Cash & Cash Equivalents | 305.10M |
| Total Debt | 5.80M |
| Net Cash | 299.30M |
| Net Cash Per Share | $6.80 |
| Equity (Book Value) | 458.37M |
| Book Value Per Share | 10.41 |
| Working Capital | 308.44M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$138.14 million and capital expenditures -$473,000, giving a free cash flow of -$138.61 million.
| Operating Cash Flow | -138.14M |
| Capital Expenditures | -473,000 |
| Depreciation & Amortization | 578,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -138.61M |
| FCF Per Share | -$3.15 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MPLT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,079.16% |
| Shareholder Yield | -1,079.16% |
| Earnings Yield | -17.29% |
| FCF Yield | -14.87% |
Analyst Forecast
The average price target for MPLT is $31.80, which is 50.21% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $31.80 |
| Price Target Difference | 50.21% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |